SCHEMBL2460164

SCHEMBL2460164

CC(=O)NC(C(N)=O)C1(C(=O)O)CCC(C2=C3C=NC=C[N+]3(N)C(c3cccc(OCc4ccccc4)c3)=N2)CC1

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.35
ACACA Q13085 3/20 0.33
MAOB P27338 1/20 0.33
IGF1R P08069 4/20 0.33
F10 P00742 3/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ADAM17 P78536 2/20 0.32
SPHK2 Q9NRA0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2457720 0.89 IGF1R (0.34) MAOBIGF1RF10JAK2JAK1
SCHEMBL2457743 0.86 KDM4E (0.34) MAOBIGF1RF10MEN1KMT2A
SCHEMBL2457738 0.85 SPHK1 (0.37) IGF1RF10SPHK2
SCHEMBL2462745 0.85 IGF1R (0.34) MAOBIGF1RF10JAK2JAK1
SCHEMBL2461705 0.85 KCNH2 (0.32) IGF1RF10JAK2JAK1SPHK2
SCHEMBL2457199 0.84 IGF1R (0.34) IGF1RF10JAK2JAK1ADAM17
SCHEMBL2460657 0.84 ADAM17 (0.39) IGF1RF10JAK2JAK1ADAM17
SCHEMBL5115303 0.82 IGF1R (0.35) IGF1RF10JAK2JAK1ADAM17
SCHEMBL2459335 0.82 IGF1R (0.44) MAOBIGF1RJAK2JAK1SPHK2
SCHEMBL5109184 0.82 IGF1R (0.34) IGF1RF10JAK2JAK1ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675860-B1 IMIDAZO[1,5-A]PYRAZINES AS TYROSINE KINASE INHIBITORS OSI PHARM INC (US) 2011-09-21 EP claimed
EP-1675860-B1 IMIDAZO[1,5-A]PYRAZINES AS TYROSINE KINASE INHIBITORS OSI PHARM INC (US) 2011-09-21 EP disclosed
US-7459554-B2 Imidazopyrazine tyrosine kinase inhibitors OSI PHARMACEUTICALS, INC. (US) 2008-12-02 US disclosed